Cancer Mucosa Antigens as a Novel Immunotherapeutic Class of Tumor‐associated Antigen

Colorectal cancer is a leading cause of cancer‐related mortality worldwide. Surgery and chemoradiation exhibit incomplete efficacy and, ultimately, 50% of patients die of metastatic disease. In the context of that unmet clinical need, immunotherapeutic approaches have enjoyed limited success, partly...

Ausführliche Beschreibung